Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Would not surprise me at all if we see $7.50 get hit again (in what hopefully will mark a triple bottom, followed by an upward rise to $10+ leading into what hopefully will be the release of excellent EXCELLENCE results, followed by the leaving behind of sub-$15 levels FOREVER!).
As always, time will tell...
Really shouldn't be a surprise to anyone here IMO...
Form 144 ANAVEX LIFE SCIENCES Filed by: MISSLING CHRISTOPHER U
10K WIZARD 12:12 PM ET 6/28/2023
http://archive.fast-edgar.com/20230628/AMZ2C22CZ22222Z222282CZZ7LO6GH3SB252
Filed on: June 28, 2023
Hey attilathehunt - Only 2 more days to hit your $11 call by end of June. Odds of it happening? hehe
FYI - Unable to calculate a potential share price based upon the information you provided below since you did not include what you believe will be their earnings...
[However, using a Price To Sales ratio of 5, the share price would be $100! Not too shabby...]
In my opinion, many of the ones that are "freaking out" are more than likely the same ones who have way more invested in AVXL than they should and/or are invested in AVXL using margin. Those types of "investors" have been and will be around forever (at least until they can no longer "afford" to be around)...
Right after Missling's release of what I hope and pray will be undeniable, unambiguous and truly excellent EXCELLENCE results!
Quote from MayoMobile's notes:
"We place Anavex's chances of succuss (sic) in this indication at 100%, which would guarantee dramatic upside after Blarcamesine hits the market."
100% chance of success!
Guarantee dramatic upside after Blarcamesine hits the market!
WOW...now that's some strong conviction! I for one sure as heck hope that MayoMobile turns out to be 100% accurate in his prediction. As always, time will tell!
Expect the number of meaningless posts to double, triple or quadruple within the next 3.5 weeks too?
Out of curiosity, did a lawyer suggest you add the disclaimer below as your signature to your posts?
Just wait until mike_dotcom replies to your message...hehe
Oh man Leo, I have to admit I totally missed it. How embarrassing :(
That Georgy boy sure is sneaky and tricky! hehe
Probably not...
No need to apologize Leo!
I'll be just fine. $15+ right around the corner anyway...hehe
[Definition of "corner" - following excellent EXCELLENCE results!...or some licensing/partnership agreement!...or another crazy, no news related Feb 2021 type price spike!]
Hey Attila - Still feeling good about your $11 call by end of June?
A single block of 1,538,147 shares purchased at $8.57 right at the 16:00:00ET close! It's definitely a buy because it was at the $8.57 ask and it is showing in green on my feed. WOW! Something's up for sure. Can't wait to see what happens next week!
"Color me old school."
Hands down you are the best with words Leo! I spit my coffee all over the keyboard reading that one LOL
FWIW
Rumor: Gary Gensler Accused Of Market Manipulation In $2.5 Million Short Position
Gary Gensler, chairperson of the U.S. Securities and Exchange Commission (SEC), has been accused of market manipulation by shorting Bitcoin (BTC) and other crypto-focused stocks.
Coinbase, one of the largest cryptocurrency exchanges, is rumored to have evidence supporting the allegations against Gensler.
https://cryptorank.io/news/feed/74898-193393-gary-gensler-accused-of-market-manipulation
Nope. I want to see if anyone else gets it first...
I guarantee you I'm the only one here who gets the meaning of that one...hehe
FWIW - AVXL began going bonkers at 12:45pm
Kudos to Lane Simonian for at least using the word "may" instead of the word "will"...
C'mon Gator328, you can't tease us with that and not give us his name!
I grew up with an undersized kid who was always a very good athlete, the best in the neighborhood. Typical big fish in a small pond story. When he signed with a D1 program on an athletic scholarship, a few of us discounted his odds for success because of his size. It wasn't until he turned pro that we had to admit we were wrong.
FWIW - News regarding ANVS:
Annovis Bio Completes Enrollment in Late-Stage Study of Buntanetap for Parkinson's Disease
MT NEWSWIRES 9:42 AM ET 6/8/2023
Symbol Last Price Change
ANVS 14.29down +0.31 (+2.2175%)
QUOTES AS OF 09:43:04 AM ET 06/08/2023
09:42 AM EDT, 06/08/2023 (MT Newswires) -- Annovis Bio(ANVS) said Thursday that it has completed the enrollment for its phase 3 study of its lead compound buntanetap, which is intended for the treatment of Parkinson's disease, a type of brain disorder.
The clinical-stage drug platform company said that, since the first patient was dosed in late August, more than 640 patients have been screened and 520 patients have been enrolled "in record time" across 67 sites.
The study is a placebo-controlled trial evaluating the drug candidate for early Parkinson's disease patients on top of their standard of care. The study is set to conclude in November, with topline assessment results available by the end of the year, the company said.
Shares of Annovis Bio(ANVS) added more than 2% in recent trading activity on Thursday.
Price: 14.35, Change: +0.37, Percent Change: +2.65
MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.
FWIW - News regarding BIIB:
Biogen's Alzheimer's Treatment Leqembi May be Eligible for Full Approval, US FDA's Advisers Say
MT NEWSWIRES 2:22 PM ET 6/7/2023
02:22 PM EDT, 06/07/2023 (MT Newswires) -- The US Food and Drug Administration's advisory panel said Wednesday that Biogen's (BIIB) Alzheimer's treatment Leqembi (lecanemab-irmb) may be eligible for full approval despite concerns about brain hemorrhage from using blood thinners with the drug.
"The benefits of lecanemab are supported by consistent results across scales and domains, slowing of progression to the next stage of disease, clinically meaningful impact on QoL or care partner burden, and consistency across subgroups," the advisers said in a report Wednesday. "The number of intracerebral hemorrhage cases was small, limiting risk assessment of concomitant use of antithrombotic."
On Friday, a panel of external advisers will meet to discuss the company's application for full approval.
Price: 308.41, Change: +8.61, Percent Change: +2.87
MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.
I would be first in line to take a $40 pps buyout today!
By the way, if a $400 pps buyout actually does happen at some point in the future, only a small percentage of my holdings will benefit...
Any serious retail holder here that would not take a $400 pps buyout today?
Not quite sure how so many posters here state their thoughts/opinions as if they are facts, but I would absolutely love to see your particular thought below come to fruition...
We will see revenue next year on Alz AA.
Did Labor Day get moved to November?
For MrPlmr: So, scout's honor, you are not a shareholder again until Labor Day. Is this correct?
Hey attilathehunt- What is your AVXL share prediction for the end of June?
Just curious to compare it to your predictions since the end of March...hehe
Same can be said when it comes to the vast majority of posters on this message board too...
When it comes to Missling,, a healthy dose of skepticism is good medicine.
AVXL better not be under $9.15 come November!
Out of curiosity, since your "after the tax loss" period begins in early July, any particular reason why you are going to be waiting until the end of November?
Completely Agree. Stock can only go down from here. I sold some at 9.15 and parked it in LWLG. Buy back in after the tax loss in end of Nov.
"My thought for what it is worth,..."
Oh man, I can't wait to see how much some of the posters here think your thought is worth! hehe
My thought for what it is worth, is Anavex will not be presenting more P2b/3 AD data at the AAIC this year. We won't see more detail on that until sometime after the Excellence readout.
Expect more patents, trial initiations etc. that cost money and won't drive potential revenue anytime soon.
FYI - Important AAIC 2023 Dates:
https://aaic.alz.org/abstracts/overview.asp
"...and will be out by end of July."
For the sake of accuracy, "will" should be replaced with "might". Of course, as an AVXL long, I certainly hope your statement of fact comes to fruition!
The AD full analysis is on the way and will be out by end of July.
No way AVXL does weekly payroll. Much more likely to be either bi-weekly or semi-monthly...
He's collecting a big fat check every week so why should he give a schitt?
Yep, it sure does. Of course, I would prefer to see it locked into a 19.50-18.75 range...hehe
Seem to be locked into
9.50-8.75 range for a while.
"Perhaps timely trading has made it a better investment."
No doubt about that!
"10-11% annualized is a FLUKE of the past 10-12 years that
investors of a certain generation MAY have come to view as NORMAL."
You got that right...
For a Risk asset that COULD have gone to zero and STILL is not dead in the long term, AVXL has done fine. Perhaps timely trading has made it a better investment. 10-11% annualized is a FLUKE of the past 10-12 years that investors of a certain generation MAY have come to view as NORMAL. I doubt that it is, or more importantly am invested that it is NOT.
Did your professor really call you "Gator"?!?
I don't know how many times the professor looked over and saw me watching the clock, but at one point he tapped me on the shoulder and said, "Gator, time will always pass. The question is whether you will?"
There is always someone throwing money away in the stock market...
someone threw money away.
I am predicting that the WGT longs will finally be rewarded with shiny and sparkling bicycles by Christmas 2024!